creating a cohort area to limit transmission of pandrug-Resistant acinetobacter baumannii in a thai tertiary care center

Clinical Infectious Diseases

Volumn 48, Issue 10, 2009, Pages 1487-1488

  Apisarnthanarak, Anucha ^a   Warren, David K ^b   Fraser, Victoria J ^b  

^a THAMMASAT UNIVERSITY HOSPITAL   (Thailand)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; HEALTH CARE UTILIZATION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; LETTER; PATIENT MONITORING; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; TERTIARY HEALTH CARE; CROSS INFECTION; DRUG EFFECT; HOSPITAL; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATIENT CARE; THAILAND;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS; HUMANS; INFECTION CONTROL; PATIENT ISOLATION; THAILAND;

EID: 65549163370     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598512     Document Type: Letter

References (5)

1. Apisarnthanarak A, Pinitchai U, Thongphubeth K, et al. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis 2008;47:760-7.
2. Ponce-de-Leon S. The needs of developing countries and the resources required. J Hosp Infect 1991;18(Suppl A):376-81.
3. Christenson M, Hitt JA, Abbott G, Septimus EJ, Iversen N. Improving patient safety: resource availability and application for reducing the incidence of healthcare-associated infection. Infect Control Hosp Epidemiol 2006;27:245-51.
4. Apisarnthanarak A, Fraser VJ. Feasibility and efficacy of infection-control interventions to reduce the number of nosocomial infections and drug-resistant microorganisms in developing countries: what else do we need? Clin Infect Dis 2009;48:22-4.
5. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC- 2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. An- timicrob Agents Chemother 2007;51:3026-9.